Treatment of Acquired Immunodeficiency Syndrome in Tuberculous Meningitis

This protocol covers the management of Acquired immunodeficiency syndrome (AIDS) in patients who have concurrent tuberculous meningitis — a clinically complex combination in which both conditions must be addressed in a carefully coordinated manner.

Clinical scenario: Patients with AIDS presenting with tuberculous meningitis require an approach that accounts for both active infections simultaneously. The timing of each intervention relative to the other is central to achieving safe clinical stabilisation.

Treatment Approach (partial summary)

Management involves tuberculosis treatment and corticosteroid therapy initiated immediately at diagnosis, with antiretroviral therapy introduced once there is evidence of clinical response — the complete sequence, criteria, and regimen details are in the full protocol.

Treatment goals: Clinical improvement and changes toward normal in CSF parameters.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1001/jama.2024.24543

For those with tuberculous meningitis, treatment for tuberculosis and high-dose corticosteroids should be initiated immediately at diagnosis, and ART initiation is recommended when tuberculous meningitis is under control, based on clinical improvement and changes toward normal in CSF parameters, generally 2 to 4 weeks thereafter (evidence rating: BIa).

View source ↗